Cerence xUI Selected as AutoTech AI Solution of the Year by AutoTech Breakthrough

(NASDAQ:CRNC), BURLINGTON, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that its hybrid, agentic AI platform, Cerence xUI(TM), was named AutoTech AI Solution of the Year in the sixth annual AutoTech Breakthrough Awards program recognizing the top companies, technologies, and […]

Catheter Precision Enters Distribution Agreement with FuMedica AG to Bring LockeT to Switzerland

(NYSE MKT: VTAK), FORT MILL, S.C., Oct. 16, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (VTAK – NYSE/American), a US based medical device company and a leading developer of innovative solutions for cardiac procedures, is pleased to announce a strategic distribution agreement with FuMedica AG, a premier Swiss medical device distributor. This partnership will introduce

Vision USA’s “Global WiFi for Biz” Redefines Corporate Connectivity and Roaming Limits

NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) — Corporate teams often face connectivity challenges while traveling domestically or internationally. “Global WiFi for Biz” simplifies global business communication, keeping teams productive wherever they go. The Challenge: Limited Mobility in a Global EconomyAlthough organizations accelerate cross-border operations, roaming fees, inconsistent eSIM coverage, and unpredictable data costs continue

Imbria Pharmaceuticals Partners with Hypertrophic Cardiomyopathy Association to Support FORTITUDE-HCM Trial Evaluating Ninerafaxstat for Non-Obstructive Hypertrophic Cardiomyopathy

Partnership further supports trial recruitment; FORTITUDE-HCM to be highlighted at upcoming HCMA Annual Patient Meeting Enrollment underway for the global, multicenter, double-blind Phase 2b trial assessing efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive HCM BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) — Imbria Pharmaceuticals, Inc., (“Imbria”), a clinical-stage company developing transformational cardiovascular disease

Rent for less than $1K: Zillow shows affordable options in these areas

Top markets for sub-$1,000 apartments and rooms for rent amid housing cost crunch — More than 50% of the apartments in Wichita, Kansas and McAllen, Texas, are listed for less than $1,000 — The median rent for a room is $1,000 or less in 86 of the 100 largest U.S. metros. — 28% of recent

Core Molding Technologies Announces Timing of Third Quarter Fiscal 2025 Results

(NYSE MKT:CMT), COLUMBUS, Ohio, Oct. 16, 2025 (GLOBE NEWSWIRE) — –Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building products, utilities, transportation and powersports industries across North America, today announces that it will release its third quarter fiscal

GCL Executes MOU to Acquire Madeviral, Aiming to Accelerate Global Growth in Game Marketing and Publishing Support

(NASDAQ:GCL),(NASDAQ:GCLWW), SINGAPORE, Oct. 16, 2025 (GLOBE NEWSWIRE) — GCL Global Holdings Ltd (Nasdaq: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced that it has entered into a non-binding Memorandum of Understanding (“MOU”) to acquire Madeviral, a Singapore-based full-service marketing agency specializing in gamer-focused marketing. Founded in 2016, Madeviral helps

KENDALL-JACKSON RELEASES FIRST-EVER CO-BRANDED WINE COLLECTION WITH NBA

Santa Rosa, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) — Kendall-Jackson, the family-owned winery behind America's #1-selling Chardonnay and the NBA's first official wine partner, proudly announces the release of its inaugural co-branded wine collection with the league. First unveiled in February during NBA All-Star 2025 in San Francisco, the collection features three wines: 2024 Lake

Stansberry Asset Management Earns 2025 Great Place To Work Certification(TM)

WESTLAKE, Texas, Oct. 16, 2025 (GLOBE NEWSWIRE) — Stansberry Asset Management (SAM) is proud to be Certified(TM) by Great Place To Work(R) for the 2nd year in a row. The prestigious award is based entirely on what current employees say about their experience working at SAM. This year, 94% of employees said it's a great

Esperion Nominates ESP-2001 as Preclinical Development Candidate for Treatment of Primary Sclerosing Cholangitis

(NasdaqGM:ESPR), – Highly-Specific Allosteric ACLY Inhibitor Designed to Target Liver and Bile Duct Injury, Inflammation, and Fibrosis Associated with Primary Sclerosing Cholangitis (PSC) and Related Diseases – – ESP-2001 Has the Potential to Meaningfully Impact the Progression of PSC, a Disease with No Approved Treatments – ANN ARBOR, Mich., Oct. 16, 2025 (GLOBE NEWSWIRE) —

Scroll to Top